文献速递肝病

饮酒与假定非酒精性脂肪性肝病患者的肝脂肪变相关

Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-11-14

基于Framingham心脏研究2475名经CT诊断肝脂肪变的参与者,横断面分析显示每周饮酒总数和单日最大饮酒量均与肝脂肪变相关(aOR分别为1.15),暴饮在饮酒者中与肝脂肪变风险增加相关(aOR 1.45),啤酒饮用者中饮酒模式与肝脂肪变相关而葡萄酒饮用者中未见。

要点

  • 在假定NAFLD人群中,每周饮酒总数和单日最大饮酒量与肝脂肪变独立相关。
  • 暴饮在假定NAFLD饮酒者中与肝脂肪变风险增加相关。
  • 啤酒饮用者中饮酒模式与肝脂肪变相关,葡萄酒饮用者中未观察到此关联。

核心结论

  • 在排除重度饮酒者的Framingham心脏研究参与者中,饮酒与肝脂肪变仍存在关联,提示饮酒可能是NAFLD的危险因素。

研究设计与样本

  • 横断面研究,纳入2475名经计算机断层扫描确定肝脂肪变的Framingham心脏研究参与者。
  • 排除重度饮酒者(女性每周饮酒超过14杯,男性每周饮酒超过21杯)。
  • 采用多变量校正逻辑回归模型评估饮酒模式与肝脂肪变的关联,校正社会人口学因素、饮食和代谢综合征组分。

主要发现

  • 样本平均年龄49.8±10.2岁,女性占50.3%,肝脂肪变患病率为17.5%。
  • 每周饮酒总杯数与肝脂肪变相关(aOR 1.15;95%CI 1.02-1.29)。
  • 单日最大饮酒杯数与肝脂肪变相关(aOR 1.15;95%CI 1.02-1.30)。
  • 暴饮发生在25.4%的假定NAFLD个体中,在饮酒者中与肝脂肪变风险增加相关(aOR 1.45;95%CI 1.06-1.98)。
  • 在 Beverage-specific 分析中,啤酒饮用者中饮酒模式与肝脂肪变相关,葡萄酒饮用者中未见关联。

临床怎么用

  • 对于假定NAFLD患者,应详细询问饮酒模式,包括每周饮酒总数、单日最大饮酒量和暴饮行为。
  • 即使未达重度饮酒标准,饮酒仍与肝脂肪变相关,临床评估NAFLD时不应忽视中度饮酒的影响。

局限性

  • 横断面设计无法确定因果关系。
  • 需要前瞻性研究验证这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Many individuals presumed to have nonalcoholic fatty liver disease (NAFLD) consume moderate amounts of alcohol. Little is known about patterns of alcohol use in patients with NAFLD or how drinking behaviors affect liver fat. METHODS: We conducted a cross-sectional study of 2475 participants of the Framingham Heart Study with hepatic steatosis, as determined by computed tomography. We performed multivariable-adjusted logistic regression models to evaluate the association between alcohol drinking patterns and hepatic steatosis. Models were adjusted for sociodemographic factors, diet, and the components of the metabolic syndrome. We excluded heavy alcohol users, defined as women who consume more than 14 alcohol drinks per week and men who consume more than 21 alcohol drinks per week. RESULTS: In our sample (mean age, 49.8 ± 10.2 y; 50.3% women), the prevalence of hepatic steatosis was 17.5%. The total number of alcohol drinks per week and the maximum drinks consumed per drinking day each were associated with hepatic steatosis (adjusted odds ratio [aOR], 1.15; 95% CI, 1.02-1.29 and aOR 1.15; 95% CI, 1.02-1.30). Binge drinking occurred in 25.4% of individuals with presumed NAFLD and was associated with an increased odds of hepatic steatosis (aOR, 1.45; 95% CI, 1.06-1.98) among alcohol users. In a beverage-specific analysis, alcohol use patterns were associated with hepatic steatosis among beer drinkers, but not among wine drinkers. CONCLUSIONS: In a cross-sectional study of participants of the Framingham Heart Study with hepatic steatosis, we observed an association between alcohol use and liver fat, even after excluding heavy alcohol users from our analysis. Alcohol use therefore appears to be a risk factor for NAFLD. Prospective studies are needed to validate these findings and determine if alcohol use should be a focus for research, prevention, and treatment of presumed NAFLD.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Long MT, Massaro JM, Hoffmann U, et al. Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2019. PMID: 31734449. doi:10.1016/j.cgh.2019.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。